# Modeling the clonal heterogeneity of stem cells

- David P Tuck
^{1}Email author and - Willard Miranker
^{2}

**7**:44

**DOI: **10.1186/1742-4682-7-44

© Tuck and Miranker; licensee BioMed Central Ltd. 2010

**Received: **30 March 2010

**Accepted: **17 November 2010

**Published: **17 November 2010

## Abstract

Recent experimental studies suggest that tissue stem cell pools are composed of functionally diverse clones. Metapopulation models in ecology concentrate on collections of populations and their role in stabilizing coexistence and maintaining selected genetic or epigenetic variation. Such models are characterized by expansion and extinction of spatially distributed populations. We develop a mathematical framework derived from the multispecies metapopulation model of Tilman et al (1994) to study the dynamics of heterogeneous stem cell metapopulations. In addition to normal stem cells, the model can be applied to cancer cell populations and their response to treatment. In our model disturbances may lead to expansion or contraction of cells with distinct properties, reflecting proliferation, apoptosis, and clonal competition. We first present closed-form expressions for the basic model which defines clonal dynamics in the presence of exogenous global disturbances. We then extend the model to include disturbances which are periodic and which may affect clones differently. Within the model framework, we propose a method to devise an optimal strategy of treatments to regulate expansion, contraction, or mutual maintenance of cells with specific properties.

## Background

The promise of therapeutic applications of stem cells depends on expansion, purification and differentiation of cells of specific types required for different clinical purposes. Stem cells are defined by the capacity to either self-renew or differentiate into multiple cell lineages. These characteristics make stem cells candidates for cell therapies and tissue engineering. Stem cell-based technologies will require the ability to generate large numbers of cells with specific characteristics. Thus, understanding and manipulating stem cell dynamics has become an increasingly important area of biomedical research. Genomic and technological advances have led to strategies for such manipulations by targeting key molecular pathways with biological and pharmacological interventions [1–3], as well as by niche or microenvironmental manipulations [4].

Recent conceptual and mathematical models of stem cells have been proposed [5–9] that extend the relevance of earlier ones [10] by focusing on the intrinsic properties of cells and effects of the microenvironment, and address new concepts of stem cell plasticity. Sieburg et al have provided evidence for a clonal diversity model of the stem cell compartment in which functionally discrete subsets of stem cells populate the stem cell pool [11]. In this model, heterogeneous properties of these clones that regulate self-renewal, growth, differentiation, and apoptosis informed by epigenetic mechanisms are maintained and passed onto daughter cells. Experimental evidence supports this notion that tissue stem cell pools are composed of such functionally diverse epigenetic clones [11]. Roeder at al, by extending their previous model to include clonal heterogeneity, have demonstrated through agent based model simulations that clonally fixed differences are necessary to explain the experimental data in hematopoietic stem cells from Sieburg [12].

Metapopulation models concentrate on collections of populations characterized by expansion and extinction and the role of these subpopulations in stabilizing coexistence and maintaining genetic or epigenetic variation. The canonical metapopulation model [13] for the abundance of a single species *p*, with colonization rate *c* and extinction rate *m*, is described by the equation *dp*/*dt* = *cp*(1-*p*) - *mp*. Both the single species model [14, 15] and multispecies models have been extensively studied [16–19], identifying various conditions under which effects such as stochasticity of the demographics or the disturbance patterns, spatial effects, habitat size, and asynchronicity, may have theoretical and practical implications, for instance in managing disturbed ecological systems.

The important and influential model of habitat destruction by Tilman [20] extended the multiple species models by including the incorporation of fixed disturbance, conceived as loss of habitat. In the present work, we modify the basic ecological framework from Tilman to model individual cells. Previous metapopulation modeling of individual cellular populations have been proposed. For example, Segovia-Juarez et al, have explained granuloma formation in tuberculosis infections by using simple metapopulation models [21].

The hierarchical structure of the Tilman model is based on a collection of a large number of patches. Each patch can be empty, or inhabited by species *i*. The species are in competition for space and ranked according to their competitive ability. When a cell expands to another patch, it can colonize either if that patch is empty or it is inhabited by species *j* having a lower rank. Analytical studies of the Tilman model have demonstrated that under certain conditions, the species will go extinct according to their competitive ranking. For instance, in the limiting model in which all species have equal mortalities, in the presence of fixed niche destruction, extinction will take place first for the strongest competitors.

We explore the outcome of the interactions of these components using mathematical models. Disturbances in the ecological models refers to externally caused deaths, In the cellular context, they could include the possibility of drug treatments or environmental toxicity. These models are also studied by simulation. In our model the role of individual species is based on individual clones with clonally fixed differences. Increasing evidence is accumulating that cell fate decisions are influenced by epigenetic patterns (such as histone methylation and acetylation status) which may distinguish various clones. Specific gene patterns render different cells uniquely susceptible to differentiation-induced H3K4 demethylation or continued self-renewal [11, 22, 23].

Unlike the Tilman model, our model treats the generalized case in which each distinct clone can have differing growth and death characteristics. Thus, the strict ordering of extinction does not occur. The model assumes competition for space within a niche among cells with differing growth and self-renewal characteristics.

Expansion and contraction of stem cell populations and the possibility for manipulation of these dynamics will be different for molecular perturbations which target intrinsic growth differentiation or apoptotic pathways or non-specific perturbations. The source of such perturbations is outside of the stem cells themselves, whether from the local microenvironment or from distal locations within the organism such as inflammation, hormonal, cytokine or cell type specific signals (anemia, thrombocytopenia). A related area is the study of subpopulations of cells within tumors that drive tumor growth and recurrence, termed cancer stem cells [24], and which may be resistant to many current cancer treatments [25]. This has led to the hypothesis that effective treatment for such cancers may require specific targeting of the stem cell population.

In this paper, we develop a mathematical framework derived from metapopulation models that can be used to study the principles underlying the expansion and contraction of heterogeneous clones in response to physiological or pathological exogenous signals. In Section 2, we present closed-form expressions for the basic model. We are able to provide closed form analysis of the model near equilibrium states. Combined with numerical simulations, this can provide novel insights and understanding into the dynamics of the phenomena that can be tested experimentally. In Section 3, we explore the effects of both intrinsic cellular characteristics and patterns of exogenous disturbances. In Section 4, we extend the model to include disturbances which may differ quantitatively for different clones. We also extend the analysis from fixed to periodic disturbances. In Section 5, we propose a method to devise an optimal strategy of applying deliberate disturbances to regulate expansion, contraction, or mutual maintenance of specific clones. Finally, in Section 6, we discuss the model and its potential applications.

## A cellular metapopulation model

*R*(

*ij*), $i=1,\mathrm{...},\overline{i},\phantom{\rule{0.5em}{0ex}}j=1,\mathrm{...},\overline{j}$ be the occurrency matrix of cell type

*j*in niche

*i*. For example in Figure 1, number the niches from 1-5, starting in the upper left-most niche (so that $\overline{i}=5$ in this case). The species are numbered 1-4 with #1 annotated with cross hatches, #2 with diagonal bricking, #3 with diagonal stripes and #4 with speckles (so that $\overline{j}=4$ in this case). Then the corresponding occurrency matrix is

be the number niches containing species $j=1,\mathrm{...},\overline{j}$.

Here the *p* _{
i
} denote the number of niches occupied by the *i*-th clone. The *c* _{
i
} denote expansion (or growth) rates, and the *m* _{
i
} extinction (or death) rates. The *c* _{
ij
} represent interactions between pairs of clones. Non-specific niche perturbations, *D*, represent exogenous disturbances which may include pharmacologic, physiologic, or pathologic causes. We extend this, in Section 4, to include clone-specific disturbances, *d* _{
i
}, represent disturbances which have different effects on the various clones.

The behavior of the model is complex; see for example Tilman [20] and Nee [26] for analyses of specific aspects of similar ecological models. We consider a number of simplifications in order to focus on the role of disturbances as deliberate manipulations that alter the expansion and contraction of clones with different fixed characteristics. We consider that each niche is fully connected to all other niches, so that spatial effects are not directly modeled. Similar to the ecological models, we make the hypothesis that clonal lineages have a ranked order in which the abundance of clone *i* within a niche is not affected by clone *j*, but clone *j* is affected by clone *i* (where *i* < *j*). Cells may be removed by either death or by differentiation.

### Nested Switches

This model has been thoroughly analyzed for species abundance in the ecological context of habitat destruction. In ecosystems, the value of D is constantly increased. Analytical studies have revealed conditions which define the order of extinction according to competitive ranking. and the richness or diversity of persisting species and the order of extinction. Such analyses have usually focused on communities with equal mortalities for all species (*m* _{
i
} = *m*) or equal colonization abilities (*c* _{
i
} = *c*). A number of studies have characterized richness or diversity of persisting species and the order of extinction [27–29]. Recent studies have focused on changes in abundance ranking [18]. More recently, Chen et al [30] have assessed the effects of habitat destruction using this model in the presence of the Allee effect. The equilibrium abundances have been studied under a variety of conditions to demonstrate that it is possible, for instance, for species which are not the best competitor to go extinct first if its colonization rate satisfies certain conditions.

We build on these previous analyses and analyze the case allowing both different mortalities and colonization rates for different clones. In this analysis, there is no fixed order of extinction, but rather we demonstrate the existence of a mathematical construct (2.6) that expresses the switching ability among potential states of the system based on differences in the disturbance. Thus, the disturbance, which represented habitat destruction in the ecosystem models, is viewed as a treatment, and our aim is to understand how different treatment choices, by modifying D, can lead to different patterns of clonal abundance. These switching possibilities suggest that clones with different characteristics may, in principle, be selected for expansion through directed, purposeful disturbances.

This shows that the equilibria ${q}_{i}^{\infty}$ have 2^{
i
}states among which they might switch. Identification of such a set of nested switches allows us to adjust the model parameters to control expansion or contraction of individual clones. In Section 3 we examine these switchings in terms of the original variables.

### Stability

The model has been widely studied in ecology. For instance, analysis of the stability of an earlier version of this model was provided by Nee [26], and detailed analysis of equilibria performed by Tilman [20, 31]. Tilman et al [32] expanded the analysis to a number of variants,based on the initial abundance and different mortality rates for better competitors. Morozov et al study the model analytically to assess changes in abundance ranking over time [18]. Other variations have also been studied including Allee effect's influence on species extinction order [30].

Our analysis of the model includes some minor modifications from previous analyses: each clone may have a different mortality and the interaction between pairs of clones is distinct (*c* _{
ij
} matrix). In the Appendix B we show that the steady state solutions *q* _{
i
}, *i* ≥ 1 of (2.3) are unconditionally asymptotically stable with the equilibrium values given in (2.6). This stability combined with the pattern of nested switches suggests that within the scope of the model, we can define predictable interventions either untargeted (based on alterations of non-specific exogenous disturbances) or targeted (based on the growth and death properties of specific clones). Moreover, the nature of the nested switches suggests that clones with different patterns of potential for self-renewal or differentiation may in principle be selected for expansion or contraction by intervening to modify specific or non-specific targets.

### Simulation of the dynamics

## Dynamics in terms of the cellular parameters

*α*

_{1}=

*c*

_{1}(1-

*D*) -

*m*

_{1}- see the schematic in (3.1). In the absence of disturbance D, this is simply the canonical single species Levins model,

*dp*/

*dt*=

*cp*(1 -

*p*) -

*mp*, in which the metapopulation will persist only if m < c. In case a disturbance is present, we see that the clone will survive if the death rate

*m*< c(1-D) (shown as the region I of

*α*

_{1}in (3.1)).

*α*

_{2}=

*β*

_{21}α

_{1}in Figure 4 is derived from the switching state [α

_{2}-

*β*

_{21}α

_{1}]+ = 0 (see (2.6)).

We see that for the population pairs (${p}_{1}^{\infty},{p}_{2}^{\infty}$): both clones will survive in domain *I*, only one (${p}_{1}^{\infty}$) survives in domain *II*, only one (${p}_{2}^{\infty}$) survives in domain *III*, and neither survives in domain *IV*. Thus we have an analytic prescription for the survival or elimination of specific clones. (The equilibrium values in (3.3) in terms of the original variables and the domain descriptions are given in Supplementary Materials). In domain *I*, we have defined conditions for mutual survival of both clones, in domain *II* and *III* we have the selective expansion of the first or second clone, respectively, while in domain *IV*, we obtain extinction of both clones.

### Mutual survival

*β*'s). Suppose ${q}_{1}^{\infty}=\theta {q}_{2}^{\infty}$, where the constant

*θ*> 0. Then from (3.2) and (3.3), we have

*α*

_{1}=

*θ*(α

_{2}-

*β*

_{21}α

_{1}). In terms of the original variables this last relation becomes

*θ*, in terms of the cellular parameters. Namely,

*q*

_{ i }> 0), we may delete the brackets in (3.7), and solve recursively for the

*α*

_{ i }. For

*i*= 1, the sums in (3.7) are empty, and it yields

*θ*

_{1}= 0, as expected. For

*i*= 2, (3.7) becomes

*q*

_{1}=

*α*

_{1}(3.8) delivers

(Inserting *α* _{2} from (3.9) into (3.10) would allow us to express *α* _{3} in terms of *α* _{1}.)

*θ*

_{ i }of

*q*

_{ i }to

*q*

_{1}) is derived by extending these arguments. We find

where *β*'s with undefined subscripts are to be set to unity. Inserting (2.4) into (3.11) we may find the value of the disturbance D that accomplishes the exact degree of mutual survival.

## Oscillations and clone specific disturbance

The model described thus far is limited in that a disturbance to the stem cell microenvironment affects all clonal lineages similarly and does not vary with time. In fact, different disturbances, such as specific cytokine concentration, inflammatory states, proliferative or apoptotic signals from the environment will differentially affect heterotypic cells that are in a particular state at a particular time point. Such perturbations are expected to vary in time with different intensities, durations, and intervals. This scenario could occur in a physiological setting, in which disturbances would occur at different periods over time and in which cell types with different characteristics or in different states of cell cycle, for instance, would respond differentially to these disturbances.

*d*

_{ i }is a population dependent constant and a harmonic time dependence is taken for the disturbance, namely

*α*

_{ i }of (2.4) become

*a*

_{ i }=

*c*

_{ i }(1 -

*d*

_{ i }) -

*m*

_{ i }. To avoid confusion, we have denoted the fixed part of

*α*

_{ i }(

*t*) (namely, the

*α*

_{ i }of (2.4)) by the symbol

*α*

_{ i }. We seek solutions for the clonal populations in the form of power series expansions in ε. In particular, take

In Appendix C, we obtain the following expression for the long time solution of ${q}_{i}^{\infty}(t)={c}_{i}{p}_{i}(t)$

*X*

_{ i }and

*Y*

_{ i }are specified in Appendix C.

Switching effects in (4.6) are expressed within both the ${q}_{i0}^{\infty}$ and the *b* _{
i
}. The harmonic oscillatory effects are displayed within the parentheses in (4.6)). Then switching and oscillatory effects characterizing ${q}_{i}^{\infty}(t),\phantom{\rule{0.5em}{0ex}}\phantom{\rule{0.5em}{0ex}}i\ge 1$ are somewhat separate to at least *O*(ε^{2}).

## Single and multiple component perturbation

Having examined the effect of different patterns of disturbances on clonal proportions, we now show how the model may be used to implement clonal expansion or clonal elimination as in cancer applications. We explore the clonal makeup of a population of functionally diverse stem cell clones under different regimens of disturbance. Here, disturbances may be deliberately applied treatments intended to lead to a specific set of clonal proportions. The objective is to find the permissible values of the disturbance parameter *D* so that any specified combination of species survives (including none). In *n*-dimensions there are 2^{
n
}such combinations, some of which impose constraints on the model parameters. In Section 5.1, we address the case of a single disturbance that affects all clones in a similar manner. In Section 5.2, we address the use of multiple disturbances that have differential effects on the various clones. For clarity, we shall only display the results of the one and the two species cases (one and two dimensions). In Section 5.3, we illustrate the steps necessary to extend the analysis to three or more species.

### Single intervention, single species protocols

There are 2 possibilities in the case of a single species: (1) survival (2) annihilation.

**(1)**
${q}_{1}^{\infty}>0$

*U*

_{1}=

*c*

_{1}> 0, we can cancel it from (5.2). Then the single species in question survives if the following constraint is imposed on the model's parameters.

*D*≥ 0 gives the following condition on

*D*.

**(2)**
${q}_{1}^{\infty}\le 0$

*D*≥ 0, we write this condition as

### Single intervention protocols, two species

There are 4 possibilities for two species: (1) both survive, (2) neither survives, (3) only the first is annihilated, and (4) only the second is annihilated.

**(1)** ${q}_{1}^{\infty}>0$ and ${q}_{2}^{\infty}>0$

There are three cases here: (i) *U* _{2} > 0, (ii) *U* _{2} < 0 and (iii) *U* _{2} = 0.

*U*

_{2}> 0: In this case, (5.9) becomes [-

*D*+

*A*

_{2}]

^{+}> 0. Combining this with the requirement (5.5) for one-dimension, gives the following range of permissible values for

*D*.

*U*

_{2}< 0: In this case, (5.9) becomes -

*D*+

*A*

_{2}< 0. Combining this with the requirement (5.5) for one-dimension, gives the following range of permissible values of

*D*.

(iii) *U* _{2} = 0: In this case, we see from (5.8) and (5.9) that ${q}_{2}^{\infty}=0$ directly.

**(2)** ${q}_{1}^{\infty}\le 0$ and ${q}_{2}^{\infty}\le 0$

_{2}]

^{+}≤ 0, or from (2.4)

If *c* _{2} = 0, (5.16) shows that (5.17) is not required, and so, (5.18) reduces to (5.7).

**(3)** ${q}_{1}^{\infty}\le 0$ and ${q}_{2}^{\infty}>0$

*c*

_{2}≠ 0 and leads to the following constraint on the model's parameters.

**(4)** ${q}_{1}^{\infty}>0$ and ${q}_{2}^{\infty}\le 0$

This reverses the two 2-dimensional cases (1)(i) and (ii), which combined with (5.5) gives

*U*

_{2}> 0:

*U*

_{2}< 0:

Finally, (iii) *U* _{2} = 0: (5.24) shows that ${q}_{2}^{\infty}$ cannot survive.

### Multiple treatment, single species protocols

In the treatment of cancer as well as in expansion of stem cells, desirable results require combinations of treatments. However, these combinations are generally unknown. We propose that this model can be used to derive optimal combinations of treatment, which take the role of disturbances. Although, methods to determine these combinations are various, we demonstrate the feasibility of the approach using a linear programming method [33].

*D*in the definition of

*α*

_{ i }in (2.4) by

*D*

_{ i }. Then with the vector

*d*= (

*d*

_{1}, ...,

*d*

_{ g }), where

*g*is the number of treatments, we write

*D*

_{ i }, (the inner product, scalar quantity), as

*d*

_{ j },

*j*= 1,2 ...,

*g*are quantities of the different treatments used and the vector

*F*

_{ i }= (

*F*

_{ ij }),

*j*= 1,2...,

*g*, where

*f*

_{ ij }is the efficacy of treatment

*j*on species

*i*. Each treatment quantity

*d*

_{ j }has a collective cost that we call

*k*

_{ j }. The objective is to minimize the total treatment cost. Many expressions for the cost may be composed. For clarity, and illustrative purpose, we use the form (

*K,d*) where

*K*= (

*k*

_{1}, ...,

*k*

_{ g }). This requires solving

subject to certain linear constraints that we shall now assemble. (Such a problem is called a linear program, i.e., minimizing a linear form by varying exogenous parameters (such as *d* _{
j
} in 5.30), subject to linear constraints on those parameters (such as in 5.31, below)) ^{33}).

More general, cost expressions would lead to a higher dimensional optimization or a non-linear optimization, any of which could, in principle, be dealt with computationally. With a single species we carry over the constraint (5.4) and the condition (5.7) to the following cases of (1) survival or (2) annihilation.

**(1)**
${q}_{1}^{\infty}>0$

*D*replaced by

*D*

_{1}and from (5.29) we have the condition on the inner product (scalar quantity)

**(2)**
${q}_{1}^{\infty}\le 0$

### Multiple treatment, two species protocols

The model allows the extension to multiple species in a straightforward manner. There are four possible states which may be attained by combining treatments for two species.

**(1)** ${q}_{1}^{\infty}>0$ and ${q}_{2}^{\infty}>0$

**(2)** ${q}_{1}^{\infty}\le 0$ and ${q}_{2}^{\infty}\le 0$

unless *c* _{2} = 0. In this latter case, we may drop this constraint, since ${q}_{2}^{\infty}=0$ directly.

**(3)** ${q}_{1}^{\infty}>0$ and ${q}_{2}^{\infty}\le 0$

**(4)** ${q}_{1}^{\infty}\le 0$ and ${q}_{2}^{\infty}>0$

unless *c* _{2} = 0, in which case, we may drop this constraint, since ${q}_{2}^{\infty}=0$ directly.

In Figure 5, solutions to an example set of linear programs are plotted to identify minimal treatment costs for achieving the desired state of expansion. The total treatment cost ((*K,d*) which has been minimized by solving a linear program for each set of parameters in a multi-treatment, two species model, is plotted against a series of values of *f* _{11}, the efficacy of the first treatment for the first species, for various values of *f* _{22}, the efficacy of the second treatment for the second species. Although the actual methods applied will depend on which parameters are available and which can be estimated, this results demonstrates how the model may be used to determine how to apply specific disturbances to reach a desired outcome.

### Multiple clones

_{1}]

^{+}in (5.40). Then using (2.3), we write (5.40) as

## Discussion

The therapeutic use of stem cells is one of the most promising frontiers in biomedical research, and has led to interest in the expansion of specific cells for specific clinical purposes. In this paper, we develop a mathematical framework derived from metapopulation models that can be used to study the principles underlying the expansion and contraction of heterogeneous clones in response to physiological or pathological exogenous signals. We show how strategies involving targeted interventions may be defined to expand or contract clonal populations with specific attributes.

The primary contribution of the model is the application of an existing metapopulation paradigm to a new domain. The model has been widely studied in ecology, incorporating the effects of exogenous disturbances. The Tilman model has been widely studied in the ecological context of habitat destruction. Most studies focused on species abundance. The original simplified model, in which the disturbance is fixed to represent irreversible habitat destruction, revealed conditions which define the order of extinction according to competitive ranking. Such analyses have usually focused on communities with equal mortalities for all species or equal colonization abilities. A number of studies have characterized richness or diversity of persisting species and the order of extinction. More recently, Chen et al [30] have assessed the effects of habitat destruction using this model in the presence of the Allee effect. The equilibrium abundances have been studied under a variety of conditions to demonstrate that it is possible, for instance, for species which are not the best competitor to go extinct first if its colonization rate satisfies certain conditions.

We build on these previous analyses and analyze the case allowing both different mortalities and colonization rates for different clones. In this analysis, there is no fixed order of extinction, but rather we demonstrate the existence of a mathematical construct that expresses the switching ability among potential states of the system based on differences in the disturbance. Thus, disturbances, which represented habitat destruction in the ecosystem models, are viewed as treatments, and our aim is to understand how different treatment choices, i.e., modification of the disturbance, can lead to different patterns of clonal abundance. These switching possibilities suggest that clones with different characteristics may, in principle, be selected for expansion through directed, purposeful disturbances.

The problem of identifying treatments which will contribute to expansion of specific lineages has not been extensively studied. Cortin et al have taken an elegant statistical approach to identifying optimal doses for expansion of megakaryocytes (MK) using cytokine cocktails, based on the design of optimal multifactorial experiments [34]. Perturbations leading to expansion of MK precursors were studied through screening cytokines. They identified a specific set of cytokines that maximized MK expansion and maturation. The group of cytokines included thrombopoietin, stem cell factor, interleukin-6, and interleukin-9 as positive regulators and erythropoietin and interleukin-8 as inhibitors of MK maturation. Flt-3 ligand also contributed to the expansion of MK progenitors. The hypothesis that fixed characteristics of heterogeneous clones could be manipulated for expansion could be tested with such a set of cytokines in the setting of relatively purified hematopoietic progenitors or in a cell line, such as the mouse EML which is a multipotent, stem-like cell line, already demonstrated to contain different cell types [35]. Existing approaches might include isolating these subpopulations and expanding them directly. However, such approaches may not be feasible in all situations, such as the requirement for in vivo manipulation as might be required for treatment of cancer stem cells, or in cases where the phenotypic characteristics of different clones might not be sufficiently understood or available to allow isolation.

Another potential use for the model is cancer stem cells. Studies have identified subpopulations of cells within tumors that drive tumor growth and recurrence [24]. Their resistance to many current cancer treatments, has made targeting the contraction of this population an area of major interest in cancer research. A recent paper from Gupta et al is interesting for the identification of existing (etoposide) and newly identified compounds (especially salinomycin in their breast cancer model) which preferentially target stem cells [36]. They also provide evidence that other compounds commonly used in cancer therapy (such as paclitaxel) may enriching for stem cells by targeting other classes of cells. A model in which a multispecies population of such cells existed could be studied in cell lines by treating with different combinations of compounds. Periodic perturbations (intermittent dosages) are common in cancer, both for theoretical reasons of efficacy and for managing toxicity and would likely be components of such interventions in practice.

The incorporation of perturbations as an aspect of the model provides a mechanism for the identification of interventions which can be utilized to expand or contract specific clones with desirable or undesirable growth characteristics. In order to demonstrate the feasibility of the approach, a linear programming approach is outlined as a protocol by means of which optimal doses of multiple interventions are calculated. In practice, values of the necessary parameters are often not known; the model also provides the rationale for an iterative experimental framework in which known doses are applied and the measurement of population sizes and proportions is then utilized to estimate unknown parameters. These estimates can be used as hypotheses to be tested by experimental studies. Growth and death parameters are generally identifiable from existing data. However the interaction among clones is probably more difficult to glean from existing datasets. Therefore an initial application of the model is to determine the interaction values for a set of clones by application of predefined interventions. In addition to the normal stem cells, the model can be applied to the heterogeneity of malignant cells in cancer and responsiveness of such cells to combinations of treatments.

If all the growth parameters of the different clones and their interactions are known, solutions to the linear program can identify optimal doses for each of the treatments that drive the cellular pool into the desired state of expansion. If estimates of the growth parameters are available, a designed experiment with fixed doses of perturbing agents can be applied to determine the minimum costs, for example, at which a specific endpoint can be achieved. An alternative use of the model would be to determine unknown parameters (such as the efficacies of treatments for specific clones, *F* _{
i
}) in an experimental setting where known doses of experimental agents are applied and outcomes measured in terms of cell proportions. These data could then be used to estimate unknown parameters.

The simulations and generalization of the model and its analysis have provided an alternative understanding of clonal heterogeneity. The mathematical framework that includes intrinsic cellular effects, interactions among clones, and exogenous effects within a single model, allows for the possibility that switching, stability, treatment protocols can become tractable features of study.

## Appendix A: Nested Switches

*i*= 1 the sum in (2.3) is empty, and so the equation for

*q*

_{1}is decoupled from the system. Writing that equation as $dt=d{q}_{1}/({\alpha}_{1}{q}_{1}-{q}_{1}^{2})$ and integrating gives

Here and hereafter we use a standard notation ${\left[x\right]}^{+}=\{\begin{array}{cc}x,& if\phantom{\rule{0.5em}{0ex}}x>0\\ 0,& otherwise\end{array}$.

*q*

_{ i }(

*t*) in the closed form (A.2) with

*α*

_{1}replaced by

*α*

_{ i }-

*Q*

_{ i }and

*q*

_{1}(0) by

*q*

_{ i }(0),

*i*≥ 1. Then, in particular, (A.4) gets replaced by

## Appendix B: Stability

*Q*

_{ i }+

*Q*

_{ i }is appended for convenience. We find in turn that

*a*

_{ i }| =

*α*

_{ i }-

*Q*

_{ i }- 2[

*a*

_{ i }]

^{+}and $-{\displaystyle \sum _{j=1}^{i-1}{\beta}_{ji}{\left[{a}_{i}\right]}^{+}}+{Q}_{i}=0$ by definition. Likewise we find that

vanishes. This is because the last two terms in the parenthesis cancel, while the first two equaling *a* _{
i
} cancel the third for *a* _{
i
} ≥ 0. For *a* _{
i
} < 0, the leading factor in (B.6), [*a* _{
i
}]^{+} = 0. We continue by induction.

*i*= 1, (B.3) becomes,

From this we see that $\underset{t\to \infty}{\mathrm{lim}}{z}_{1}=0$, giving unconditional global stability for *q* _{1}(*t*).

*q*

_{ j }(

*t*), for all

*j*≤

*i*, the equation for

*z*

_{ i+1}, may be written as

From this we see that $\underset{t\to \infty}{\mathrm{lim}}{z}_{i+1}=0$, completing the induction.

## Appendix C: Switching Effects with Oscillations

^{ k }in what results to zero, we find the following differential equations for the coefficients

*q*

_{ ik }in the expansion in (4.5).

*k*= 0, (4.6) yields

*a*

_{ i }replacing

*α*

_{ i }. Then referring to (B.5)-(B.7), we find for the limiting equilibrium value ${q}_{i0}^{\infty}$ of

*q*

_{ i0}(

*t*), the analogous nested set of switches as for the ${q}_{i}^{\infty}$ in (B.7). Namely

*α*

_{ i }=

*a*

_{ i }. Continuing, we see that for

*k*= 1, (D.1) becomes

*i*= 1, the leftmost sum in (D.5) is empty. Then replacing

*q*

_{10}in (D.5) by its asymptotic value ${q}_{10}^{\infty}$ (as given in (D.4)) yields

*t*) here, we find (since

*b*

_{1}< 0) the following asymptotic form for

*q*

_{11}(

*t*).

*b*

_{ i }≤ 0 by inserting (D.3) into (D.15). Namely,

*X*

_{ j }and the

*Y*

_{ j }are to be specified. Inserting (D.18) into (D.16), and then inserting the resultant expression for

*F*

_{ i }(

*t*) into (D.13), the latter becomes

*b*

_{ i }< 0, analogy to (D.6)-(D.8) allows us to develop the following asymptotic form of

*q*

_{ i1}(

*t*).

This specification of *X* _{
i
} and *Y* _{
i
} completes the induction.

*q*

_{ i }(

*t*) given in (4.5) as (identical to (4.6))

## Declarations

### Acknowledgements

The authors thank Jose Costa for discussions and suggestions.

## Authors’ Affiliations

## References

- Unger C, Kärner E, Treschow A, Stellan B, Felldin U, Concha H, Wendel M, Hovatta O, Aints A, Ahrlund-Richter L, Dilber MS: Lentiviral-mediated HoxB4 expression in human embryonic stem cells initiates early hematopoiesis in a dose-dependent manner but does not promote myeloid differentiation. Stem Cells. 2008, 26 (10): 2455-66. 10.1634/stemcells.2007-0876.View ArticlePubMedGoogle Scholar
- Gonzalez-Murillo A, Lozano ML, Montini E, Bueren JA, Guenechea G: Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors. Blood. 2008, PMID: 18684860Google Scholar
- Scarfì S, Ferraris C, Fruscione F, Fresia C, Guida L, Bruzzone S, Usai C, Parodi A, Millo E, Salis A, Burastero G, De Flora A, Zocchi E: Cyclic ADP-Ribose-Mediated expansion and stimulation of human mesenchymal stem cells by the plant hormone abscisic acid. Stem Cells. 2008, PMID:18687991Google Scholar
- Schaffer D: Exploring and Engineering Stem Cells and their Niches. Curr Opin Chem Biol. 2007, 11 (4): 355-356. 10.1016/j.cbpa.2007.07.001.PubMed CentralView ArticlePubMedGoogle Scholar
- Abkowitz JL, Golinelli D, Guttorp P: Strategies to expand transduced hematopoietic stem cells in vivo. Molecular Therapy. 2004, 9: 566-576. 10.1016/j.ymthe.2004.01.014.View ArticlePubMedGoogle Scholar
- Roeder I, Kamminga LM, Braesel K: Competitive clonal hematopoiesis in mouse chimeras explained by a stochastic model of stem cell organization. Blood. 2005, 105: 609-616. 10.1182/blood-2004-01-0282.View ArticlePubMedGoogle Scholar
- Kirkland MA: A phase space model of hemopoiesis and the concept of stem cell renewal. Exp Hematol. 2004, 32: 511-519. 10.1016/j.exphem.2004.02.013.View ArticlePubMedGoogle Scholar
- Quesenberry PJ, Colvin GA, Lambert JF: The chiaroscuro stem cell: a unified stem cell theory. Blood. 2002, 100 (13): 4266-71. 10.1182/blood-2002-04-1246.View ArticlePubMedGoogle Scholar
- Hotton S, Colvin ME: Analytic formulas for discrete stochastic models of cell populations with both differentiation and de-differentiation. J Theor Biol. 2007, 245: 610-26. 10.1016/j.jtbi.2006.11.006.View ArticlePubMedGoogle Scholar
- Till JE, McCulluch EA, Siminovich L: A stochastic model of stem cell proliferation based on the growth of spleen colony-forming cells. Proc Natl Acad Sci. 1964, 51: 29-36. 10.1073/pnas.51.1.29.PubMed CentralView ArticlePubMedGoogle Scholar
- Sieburg HB, Cho RH, Dykstra B: The hematopoietic stem cell compartment consists of a limited number of discrete stem cell subsets. Blood. 2006, 107: 2311-2316. 10.1182/blood-2005-07-2970.PubMed CentralView ArticlePubMedGoogle Scholar
- Roeder I, Horn K, Sieburg H, Cho R, Muller-Sieburg C, Loeffler M: Characterization and quantification of clonal heterogeneity among hematopoietic stem cells: a model-based approach. Blood. 2008, 112 (13): 4874-4883. 10.1182/blood-2008-05-155374.PubMed CentralView ArticlePubMedGoogle Scholar
- Levins R: Some demographic and genetic consequences of environmental heterogeneity for biological control. Bulletin of the Entomological Society of America. 1969, 15: 237-240.View ArticleGoogle Scholar
- Hassell MP, Comins HN, May RM: Species coexistence and self-organising spatial dynamics. Nature. 1994, 370: 290-292. 10.1038/370290a0.View ArticleGoogle Scholar
- Hassell MP, Comins HN, May RM: Spatial structure and chaos in insect population dynamics. Nature. 1991, 353: 255-258. 10.1038/353255a0.View ArticleGoogle Scholar
- Bonsall MB, Bull JC, Pickup NJ, Hassell MP: Indirect effects and spatial scaling affect the persistence of multispecies metapopulations. Proc Biol Sci. 2005, 272 (1571): 1465-1471. 10.1098/rspb.2005.3111.PubMed CentralView ArticlePubMedGoogle Scholar
- Childs DZ, Bonsall MB, Rees M: Periodic local disturbance in host-parasitoid metapopulations: host suppression and parasitoid persistence. J Theor Biol. 2004, 227 (1): 13-23. 10.1016/S0022-5193(03)00293-5.View ArticlePubMedGoogle Scholar
- Morozov A, Li B: Abundance patterns in multi-species communities exposed to habitat destruction. Journal of Theoretical Biology. 2008, 251 (4): 593-605. 10.1016/j.jtbi.2008.01.011.View ArticlePubMedGoogle Scholar
- Hanski I: Metapopulation Biology. 1997, Academic Press, San Diego, CaliforniaGoogle Scholar
- Tilman D, May RM, Lehman CL, Nowak MA: Habitat destruction and the extinction debt. Nature. 1994, 371: 65-66. 10.1038/371065a0.View ArticleGoogle Scholar
- Segovia-Juarez JL, Ganguli S, Kirschner D: Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model. J Theor Biol. 2004, 231 (3): 357-76. 10.1016/j.jtbi.2004.06.031.View ArticlePubMedGoogle Scholar
- Cui K, Zang C, Roh T, Schones DE, Childs RW, Peng W: Chromatin Signatures in Multipotent Human Hematopoietic Stem Cells Indicate the Fate of Bivalent Genes during Differentiation. Cell Stem Cell. 2009, 4 (1): 80-93. 10.1016/j.stem.2008.11.011.PubMed CentralView ArticlePubMedGoogle Scholar
- Orford K, Kharchenko P, Lai W, Dao MC, Worhunsky DJ, Ferro A: Differential H3K4 methylation identifies developmentally poised hematopoietic genes. Dev Cell. 2008, 14 (5): 798-809. 10.1016/j.devcel.2008.04.002.View ArticlePubMedGoogle Scholar
- Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003, 100 (7): 3983-3988. 10.1073/pnas.0530291100.PubMed CentralView ArticlePubMedGoogle Scholar
- Fillmore C, Kuperwasser C: Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Research. 2008, 10 (2): R25-10.1186/bcr1982.PubMed CentralView ArticlePubMedGoogle Scholar
- Nee S, May R: Dynamics of metapopulations: habitat destruction and competitive coexistence. J Anim Ecol. 1992, 61: 37-40. 10.2307/5506.View ArticleGoogle Scholar
- Klausmeier CA, Tilman D: Spatial models of competition. Competition and Coexistence. Ecological Studies. Edited by: Sommer U, Worm B. 2002, Springer, Berlin, 161: 43-78.View ArticleGoogle Scholar
- Stone L: Biodiversity and habitat destruction: a comparative study of model forest and coral reef ecosystems. Proc R Soc B. 1995, 261: 381-388. 10.1098/rspb.1995.0163.View ArticleGoogle Scholar
- Klausmeier CA: Extinction in multispecie s and spatially explicit models of habitat destruction. Am Nat. 1998, 152: 303-310. 10.1086/286170.View ArticlePubMedGoogle Scholar
- Chen L, Hui C: Habitat destruction and the extinction debt revisited: The Allee effect. Mathematical Biosciences. 2009, 221 (1): 26-32. 10.1016/j.mbs.2009.06.003.View ArticlePubMedGoogle Scholar
- Tilman D: Competition and Biodiversity in Spatially Structured Habitats. Ecology. 1994, 75 (1): 2-16. 10.2307/1939377.View ArticleGoogle Scholar
- Tilman D, Lehman CL, Yin C: Habitat destruction, dispersal, and deterministic extinction in competitive communities. Am Nat. 1997, 149: 407-435. 10.1086/285998.View ArticleGoogle Scholar
- Gass , Saul : Linear Programming: methods and applications. 2003, New York and London: Mcgraw-Hill Book Co. Inc, 5Google Scholar
- Cortin V, Garnier A, Pineault N, Lemieux R, Boyer L, Proulx C: Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design. Experimental Hematology. 2005, 33 (10): 1182-1191. 10.1016/j.exphem.2005.06.020.View ArticlePubMedGoogle Scholar
- Ye Z, Kluger Y, Lian Z, Weissman SM: Two types of precursor cells in a multipotential hematopoietic cell line. Proc Natl Acad Sci USA. 2005, 102 (51): 18461-18466. 10.1073/pnas.0509314102.PubMed CentralView ArticlePubMedGoogle Scholar
- Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES: Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening, Cell. 2009, 138 (4): 645-659.Google Scholar

## Copyright

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.